Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients - Wikidata - awgldk - TriplyDB

Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients

Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients

http://www.wikidata.org/entity/Q35179836

about

Role of insulin in the type 2 diabetes therapy: past, present and future Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review The metabolic and mitogenic properties of basal insulin analogues Impact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control study Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies Latest insights into the risk of cancer in diabetes Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Insulin glargine and cancer risk in patients with diabetes: a meta-analysis.Metformin and breast cancer risk: a meta-analysis and critical literature review.Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin Diabetes, glucose control, glucose lowering medications, and cancer risk: a 10-year population-based historical cohort Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.The effect of metformin on breast cancer outcomes in patients with type 2 diabetes Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Cancer specific mortality in insulin-treated type 2 diabetes patients.Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study.Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.Associations between diabetes medication use and risk of second breast cancer events and mortality Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.The insulin receptor: a new target for cancer therapy.Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Insulin therapy and cancer in type 2 diabetes.Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studies Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.Insulin therapy and cancer.Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Sex and gender influences on pharmacological response: an overview.Does Metformin Reduce Cancer Risks? Methodologic Considerations.Type 2 diabetes, insulin treatment and prognosis of breast cancer.Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.

P2860

Q22241148-41AD6281-5568-4737-BCC0-2BB3151DAD97 Q26765139-37D9BEA7-3D49-423A-BDBA-4819384AC259 Q26823071-C1E7D874-BD38-4865-9A4E-149529D32683 Q26850912-CAE53724-9899-469B-A64E-38FE10D611B9 Q26991486-B81BDFEF-1B3F-4D60-B6F3-56DEACC8A390 Q28535372-2D9D5552-DE02-400F-A6B8-416A3B3E16F8 Q28542914-25D5F653-A811-4987-8524-F8024AD9D78B Q33588852-23DB3ECA-E249-40F3-B9F4-0E069B468A47 Q34135248-1859742A-A997-4804-8758-DD4914F53E16 Q34320632-058A91F7-6C2A-4045-8E0B-ABCD9AF0C967 Q34357389-5EA9F2DC-AB38-49F0-9539-B99C8C48FFC4 Q34373861-42D4F760-CB05-4623-846E-30FFBEC91228 Q34392021-CD871826-2CFC-43D3-86D8-EB9EDC743F5C Q34899291-AB5071CA-8D0A-44CD-A9DA-D462DD4DB0D0 Q34998627-80AB63D9-D780-4A54-8701-97053E88F4F7 Q35000522-1B9D7765-E23B-44CA-ADD9-919D08AF50F2 Q35038355-E82900C4-FDA3-4869-B175-5DB23CB47D06 Q35131192-A6F45FA4-83EA-430F-BF00-2E231D1D15A7 Q35587424-3247F442-51E2-4E4C-B6B8-A544172F5E58 Q35842470-8E9195C2-4852-40EB-A3DF-08C28CEEE194 Q35850213-64CD295D-DCBC-4972-BF14-9B2117701DAA Q35937961-692C5F89-A9ED-4E5F-A42C-A7672F6473F6 Q35972002-B72BE2D6-E94E-4026-B433-D284A2C749D9 Q36145731-C9886F7D-AB5E-42C6-B555-3D4A41AD42A5 Q36182935-98B777DD-1EA1-4C4F-B120-EDA81FD3A301 Q36417868-D494D28A-AF1F-4AB4-92CF-246F575251DA Q36560372-0C9D6AF9-5CD3-4F13-A521-EEBF474CE37E Q36712191-BF7BF7A9-B2A4-442C-BC25-222171FFB370 Q37176065-48B45E69-A257-40AA-A01E-859BE5D9EEFE Q37228939-DCB4374A-BEF5-4C65-A141-37DE392C3C73 Q37278227-EA50E8E2-F0F9-4A63-A924-ACAA0BCD9FE2 Q37331188-983594F1-710A-41B5-B005-471580277762 Q37428521-3723F9A8-1290-4AFC-841B-1341A4483037 Q37577175-B235F925-9D40-4C80-B6D3-E17D4B09F870 Q37982674-07AE0319-F4EC-4031-94D1-FCD83E95A67A Q38080666-0E859139-5F38-46B6-9031-E64C463A18A8 Q38214338-5C4B87CE-60B5-4E4B-AFA5-D3927F15C56C Q38687543-76E05BAA-6BB3-48CB-8C5D-70BD3741545E Q38835481-37EB82BB-9C5C-4BC8-99E2-F27910E4F0F0 Q38999875-6A68DA3B-57D5-4699-9285-157F27C73863

P2860

Further exploration of the relationship between insulin glargine and incident cancer: a retrospective cohort study of older Medicare patients

http://www.wikidata.org/entity/Q35179836

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Further exploration of the rel ...... udy of older Medicare patients

@ast

Further exploration of the rel ...... udy of older Medicare patients

@en

type

label

Further exploration of the rel ...... udy of older Medicare patients

@ast

Further exploration of the rel ...... udy of older Medicare patients

@en

prefLabel

Further exploration of the rel ...... udy of older Medicare patients

@ast

Further exploration of the rel ...... udy of older Medicare patients

@en

P1433

Q35179836-0B7530D6-3998-4644-A65C-14054353102B

P1476

Q35179836-DD582ED2-7122-46CA-AB3D-707F1476AE74

P2093

Q35179836-8343E849-9AA3-47D7-884E-BEE21DE9A099

Q35179836-8C29868F-8217-4F2F-97E1-12D69A5E4FDB

Q35179836-928E2C82-CA4D-4EF9-900B-2414B9C926D4

Q35179836-B527DC41-8C19-4AC7-9149-2C8B2B0DD715

Q35179836-D9AC3ACA-0F0E-4057-8A6A-AA948C9E0062

Q35179836-F7C4CC90-C74F-49CF-8D35-5EDE94FDA2D8

P2860

Q35179836-0FE62D1E-ABB2-4805-BA47-135DB5FE30A5

Q35179836-1B520885-B525-4EFC-99D3-6FC684828D51

Q35179836-39A27C35-6F0E-4B5A-B90A-B5E258D16EDC

Q35179836-4953E5C5-1FAC-4D01-8AD2-DF1BDFD1D365

Q35179836-59A22144-A074-45B4-BEDD-C94F7BCE65D7

Q35179836-74BF696B-FC81-46D4-9347-4F00BA4DCFAB

Q35179836-8786D806-A512-4194-AACE-C4C31981F1E9

Q35179836-8A77B8F0-F6FC-44B4-927C-362EABB3B32F

Q35179836-93D9B406-7955-4284-B8B5-B562BB6274B2

Q35179836-96FDB508-1626-44F7-88AB-EC67ED22308F

P304

Q35179836-8C540327-3D2D-4E92-BF5F-C3CDD84CB32B

P31

Q35179836-42C0F429-48A6-4174-A75E-B98845A5C907

P356

Q35179836-70B1FB51-A4F4-4E45-B9E7-5F3FE05F3DEB

P407

Q35179836-07E99248-4ABF-4EB1-9294-69487458B794

P433

Q35179836-5855C09B-F99C-4789-8359-D212268F299C

P478

Q35179836-4B557CF8-47F5-4940-AC50-5E211E6F9DF7

P577

Q35179836-727E0AFE-493B-4B61-B4D2-681102EBE672

P5875

Q35179836-751001E2-55CE-45F9-8E7B-C229041D258A

P698

Q35179836-911BAA05-C19D-4D66-AB03-B04F1290A172

P932

Q35179836-DFAE2D09-E1F6-46B7-A3B2-D51974B85DB6

P356

P1433

P1476

Further exploration of the rel ...... udy of older Medicare patients

@en

P2093

Jeremy Smith

http://www.w3.org/2001/XMLSchema#string

Jonathan Skinner

http://www.w3.org/2001/XMLSchema#string

Murray Korc

http://www.w3.org/2001/XMLSchema#string

Nancy E Morden

http://www.w3.org/2001/XMLSchema#string

Stephen K Liu

http://www.w3.org/2001/XMLSchema#string

Todd A Mackenzie

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

Diabetes and cancer: a consensus report.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Metformin and reduced risk of cancer in diabetic patients

Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data.

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Metabolic syndrome, hyperinsulinemia, and cancer.

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

P304

1965-1971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-0699

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51508312

http://www.w3.org/2001/XMLSchema#string

P698

21775752

http://www.w3.org/2001/XMLSchema#string

P932

3161263

http://www.w3.org/2001/XMLSchema#string